Arthritis of Hip
13
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
23%
3 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Nexus Evaluation Primary Trident II Uncemented Shell
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
Health Coaching for Patients Waiting for Total Hip or Knee Replacements
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty
Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty
Medial Wedge Insoles to Improve Gait in Persons After Total Hip Replacement
Better Before - Better After: Prehabilitation Program for Older Patients Awaiting Total Hip Replacement
Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty
Bioavailability of Intranasal Dexmedetomidine
Immediate Post-THA Functional Assessment
Study of Hip and Knee Arthroplasty in South Africa
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial